Covered recipient · General Payments record
CHRISTINE GASBARRO WILLIAMS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,725.87
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $322.99 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $157.40 | 3 |
| SHIELD THERAPEUTICS INC | $29.90 | 2 |
| ABBVIE INC. | $27.27 | 2 |
| GlaxoSmithKline, LLC. | $26.50 | 1 |
| Lilly USA, LLC | $23.11 | 1 |
| Mylan Specialty L.P. | $21.75 | 1 |
| PFIZER INC. | $21.06 | 1 |
| Teva Pharmaceuticals USA, Inc. | $16.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $13.84 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108414627 | CMS |
| ABBVIE INC. | $13.43 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108414629 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.21 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104556586 | CMS |
| AstraZeneca Pharmaceuticals LP | $114.30 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105600817 | CMS |
| AstraZeneca Pharmaceuticals LP | $23.89 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104463882 | CMS |
| GlaxoSmithKline, LLC. | $26.50 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115970532 | CMS |
| Lilly USA, LLC | $23.11 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135626477 | CMS |
| Mylan Specialty L.P. | $21.75 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147353870 | CMS |
| PFIZER INC. | $21.06 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131565706 | CMS |
| SHIELD THERAPEUTICS INC | $15.36 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150120919 | CMS |
| SHIELD THERAPEUTICS INC | $14.54 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150131162 | CMS |
| Teva Pharmaceuticals USA, Inc. | $16.00 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151489323 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.